1. Home
  2. AIT vs BBIO Comparison

AIT vs BBIO Comparison

Compare AIT & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Industrial Technologies Inc.

AIT

Applied Industrial Technologies Inc.

HOLD

Current Price

$304.64

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$70.30

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIT
BBIO
Founded
1923
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
12.7B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AIT
BBIO
Price
$304.64
$70.30
Analyst Decision
Buy
Strong Buy
Analyst Count
5
25
Target Price
$317.50
$86.33
AVG Volume (30 Days)
235.1K
2.9M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
0.69%
N/A
EPS Growth
2.95
N/A
EPS
7.79
N/A
Revenue
$21,485,000.00
$502,076,000.00
Revenue This Year
$7.79
$89.45
Revenue Next Year
$5.45
$73.78
P/E Ratio
$39.19
N/A
Revenue Growth
N/A
126.26
52 Week Low
$218.48
$31.77
52 Week High
$317.10
$84.94

Technical Indicators

Market Signals
Indicator
AIT
BBIO
Relative Strength Index (RSI) 53.97 52.58
Support Level $253.92 $69.62
Resistance Level $309.67 $78.96
Average True Range (ATR) 6.64 2.90
MACD -1.72 0.21
Stochastic Oscillator 41.90 92.68

Price Performance

Historical Comparison
AIT
BBIO

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: